From October 1, 2023 to November 17, 2023, the company has repurchased 6,106,800 shares, representing 0.54% for CNY 100.02 million. With this, the company has completed the repurchase of 9,015,780 shares, representing 0.8% for CNY 150 million under the buyback announced on September 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.99 CNY | +0.20% | -0.60% | -0.99% |
04-29 | Jilin Aodong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-17 | Aodong Medicine's 2023 Profit Declines 18%; Revenue Up 20% | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-0.99% | 2.48B | |
+29.98% | 682B | |
+31.73% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.77% | 240B | |
+9.46% | 209B | |
-9.00% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- 000623 Stock
- News Jilin Aodong Pharmaceutical Group Co., Ltd.
- Tranche Update on Jilin Aodong Pharmaceutical Group Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.